期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

亮氨酸脱氢酶研究进展及其工业应用 被引量：4

Research Progress and Industrial Application of Leucine Dehydrogenase
在线阅读 下载PDF
导出
摘要 微生物脱氢酶催化羰基不对称还原制备光学纯氨基酸及其衍生物具有非常大的优势。亮氨酸脱氢酶能选择性地催化α-酮酸,氨化还原得到α-氨基酸及其衍生物。本文综述了亮氨酸脱氢酶的来源,理化性质,底物特异性,酶基因工程菌构建等方面的内容及研究进展。从辅酶再生策略,酶膜反应器两方面讨论了其工业化应用,并展望了今后的发展前景。 Microbial dehydrogenase, such as leucine dehydrogenase （LDH）, has great advantages in the synthesis of optical amino acid and its derivatives by asymmetrical reductions of carbonyl compounds. This review covers the lat- est development of LDH from various sources, studies of its biochemical property, substrate specificity, kinetics of enzyme-catalyzed reactions as well as construction of engineering bacteria. Furthermore, its industrial application is discussed from the aspects of cofactor regeneration strategy and enzyme-membrane reactor and future development is also illustrated.
作者 黄春辉 林陈水
机构地区 浙江工业大学药学院
出处 《氨基酸和生物资源》 CAS 2012年第2期16-20,共5页 Amino Acids & Biotic Resources
关键词 亮氨酸脱氢酶 辅酶再生 酶膜反应器 leucine dehydrogenase cofactor regeneration enzyme-membrane reactor
分类号 Q814 [生物学—生物工程]
  • 相关文献

参考文献31

  • 1Hermann T. Industrial production of amino acids by coryneform bacteria[J]. Biotechnol, 2003, 104: 155- 172.
  • 2Bommarius A S,Schwann M. Synthesis and use of enantiomerically pure tert-leucine [ J ]. Tertrahedron Asymmetry, 1995,6 (12) : 2851.
  • 3郑栋,浦家齐.光学活性叔亮氨酸合成的研究进展[J].氨基酸和生物资源,2003,25(4):14-19. 被引量：3
  • 4Sanwal B D, Zink M W. L-Leucine dehydrogenase of Bacillus cereus [J]. Arch Biochem Biophys, 1961,94: 430-435.
  • 5Hermier J, Rousseau M, Zevaco, C. Role des deshydrogenases d nicotinamide adenine dinucleotide dans la phase initiale de la germination chez la spore de Bacillus subtilis [J]. Ann Inst Pasteur, 1970,118 : 611-625.
  • 6Ohshima T, Misono H, Soda K. Determination of branched-chain L-amino acids and their keto-analogs with leucine dehydrogenase [J]. Agrie Biol Chem, 1978,42 : 1919-1922.
  • 7李圃,吴鸿君,王贤文,向彬.脲酶-亮氨酸脱氢酶偶联法测定尿素的方法学评价[J].四川医学,2005,26(11):1234-1235. 被引量：2
  • 8Oki T, Shirai M, Ohshima T, et al. Antitumor activities of bacterial leucine dehydrogenase and glutaminase A[J]. FEBS Lctt, 1973,33,286-288.
  • 9Werner H,Kula M R. Dehydrogenases for the synthesis of chiral componds[J]. Eur J Bioehem, 1989,184.. 1-13.
  • 10Ohshima T, Misono H, Soda K. Properties of crystalline leucine dehydrogenase from Bacillus sphaericus [J]. Biol Chem, 1978,253..5719-5725.

二级参考文献82

  • 1张灿丽.用HPLC法测定L-亮氨酸[J].食品科技,2003,28(6):77-78. 被引量：3
  • 2黄志华,刘铭,王宝光,张延平,曹竹安.甲酸脱氢酶用于辅酶NADH再生的研究进展[J].过程工程学报,2006,6(6):1011-1016. 被引量：26
  • 3徐娴,贾红华,何冰芳,韦萍.甲酸脱氢酶基因在大肠杆菌Rosetta中的高效表达[J].食品与发酵工业,2007,33(5):5-8. 被引量：13
  • 4[1]Bommarius A S,Schwarm M,Stingl K,Kottenhahn M,Huthmacher K,Drauz k.Synthesis and Use of Enantiomerically Pure tert-Leucine[J]. Tetrahedron Asym metry,1995,6(12):2851～2888.
  • 5[2]a) Hon S W,Li C H,Kuo J H,Barhate N B,Liu Y H,Wang Y,Chen C T.Catalytic a symmertric coupling of 2-naphthols by chiral tridentate oxavanadium(IV) complexes[J]. Org. Lett., 2001,3(6), 869～872; b) Hoshino Y, Yamamoto H. J. Novel α-a mino acid-based hydroxamic acid ligands for vanadium-catalyzed asymmetric epoxid ation of alylic alcohols[J]. J.Am.Chem. Soc.2000,122(42):10452～10453; c) Imai Y, Zhang W B, Kida T, Nakatsuji Y, Ikeda I. Novel chiral bisoxazoline ligands with a biphenyl backbone: preparation, complexation, and applicatipn in asymmetric catalytic reactions[J]. J. Org. Chem., 2000, 65(11): 3326-3333; d)Saitoh A, Achiwa K, Tamaka K, Morimoto T. Versatile chiral bidentate ligend formα-amino acid: synthetic application and mechanistic consideration in the palladium-medrated asymmetric alylic substitutions[J]. J. Org. Chem., 2000,65(14): 4227～4240.
  • 6[3]a) Xu Z M,Sigh J,Schwinden M D,Zheng B,Kissick T P,Patel B,Humora M J,Quiroz F,Dong Z,Hsieh D M,Heikes J E,Pudipeddi M,Lindrud M D,Srirastava S K,Kronent hal D R,Mueller D R.Process research and development for an efficient synthesis of the HIV protase inhibitor BMS-232632[J].Org.Proc.Res.& Dev.2002,6(3): 323 ～328;b) Benderb S L,Abreo M A.U.S.Metalloproteinase inhibitors,pharmaceutical compositions containing them and their pharmaceutical uses[P].US 5 985 900,1999;c) Prasad J V N V,Loo J A,Boyor F E,Stier M A,Gogliotti R D,Turner W J,Harvey P J,Kramer M R,Mack D P,Scholten J D,Gracheck S J,Domagala J M.2,2-Dithiobibenzam ides derived from α,β-and γ-aminoacid processing anti-HIV activities:synthes is and structure-activity relationship.Bioorg[J].Med.Chem.1998,6(10):1707～1730.
  • 7[4]a) Levin J I,Chem J M,Cole D C,Du M T,Laakso L M.Preparation of acetylenic α-amino acid-based sulfonamide hydroxamic acid TACE inhibitors[P].U.S.US 6 225 311,2001;b) Davidsen S K,Folrjancic A S,Sheppard G S,Giesler J R,Xu L H,Guo Y,Curtin M L,Michaelides M R,Wada C K,Holms J H.Preparation of [(aroylalkyl)am ino]succinylhydroxamic acid and analogs as inhibitors of matrix metrix metallop rotenases and TNFα secretion[P].U.S.US 5 985 911,1999; c) Dragovich P S,Prins T J,Zhou R,Fuhrman S A,Patick A K,Matthews D A,Ford C E,Meador J W,Ferre R A,Worland S T.Structue-based design,synthesis,and biological evaluation of irreversi ble human rhinovirus 3c protease inhibitors[J].J.Med. Chem.1999,42(7):1203～1212.
  • 8[5]a) Kelvin S.Petides containing N-substituted D-amino acid for preventing β -strand association[P].PCT Int.Appl.WO 01 07 474,2001;b) Yomada K,Hirose M,Iwaasa H.PCT Int.Appl.Preparation of N-acyltetrahydroisoquindine derivatives as orexin receptor antagonists[P]. WO 01 85 693, 2001.
  • 9[6]Greenstein J P,Winitz M.Chemistry of the Amino Acid[M],Vol.3;John Wiley &Sons:New York,1961,pp.2580～2588.
  • 10[7]Clive D L J,Etkin N.Synthesis of α-amino acid by addition of putative a zidoradicals to α-methoxy acrylonitriles erived from aldehydes and ketones[J ].Tetrahedron Lett.1994,35:2459～2462.

共引文献31

同被引文献32

  • 1张翀,邢新会.辅酶再生体系的研究进展[J].生物工程学报,2004,20(6):811-816. 被引量：21
  • 2黄志华,刘铭,王宝光,张延平,曹竹安.甲酸脱氢酶用于辅酶NADH再生的研究进展[J].过程工程学报,2006,6(6):1011-1016. 被引量：26
  • 3Miyoshi Y, Nagano M, Ishigo S, et al. Chiral amino acid analy- sis of Japanese traditional Kurozu and the developmental changes during earthenware jar fermentation processes [ J ]. Journal of Chromatography B, 2014, 966:187-192.
  • 4Taylor P P, Pantaleone D P, Senkpeil R F. et al. Novel biosyn- thetic approaches to the production of unnatural amino acids using transaminases[J]. Trends Biotechnol,1998,16(10) :412-418.
  • 5Bajusz S, Szell E, Bagdy D, et al. Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl deriva- tive, D-MePhe-Pro-Arg-H [ J ]. J Med Chem, 1990, 33 : 1729- 1735.
  • 6Stinson S C. Chiral drugs [ J ]. Chem Eng News, 1995,73 (41) : 44-74.
  • 7Hulme A N, Meyers A I. Asymmetric synthesis of 1,1-disubsti- tuted tetralins and dihydronaphthalenes by diastereoselective addi- tion of lithiosilanes to chiral naphthalenes [ J ]. J Org Chem, 1994, 59 (5) :952-953.
  • 8Hong E Y, Cha M, Yun H, et al. Asymmetric synthesis of L- tert-leucine and L-3-hydroxyadamantylglycine using branched chain aminotransferase[ J]. J Mol Catal B Enzymatic, 2010, 66 (1-2) :228-233.
  • 9Lehr P, Billieh A, Charpiot B, et al. Inhibitors of human immu- nodefieieney virus typel protease containing 2-aminobenzyl-sub- stituted 4-amino-3 -hydroxy-5-phenylpentanoie acid : synthesis, ac- tivity, and oral bioavailability [ J']. Med Chem, 1996,39 ( 10 ) : 2060-2067.
  • 10李鑫,姜婷,欧阳嘉等.一种亮氨酸脱氢酶和编码该脱氢酶的基因:中国,CNl04031892A[P].2014-09-10.

引证文献4

二级引证文献7

氨基酸和生物资源
2012年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部